- CD43 Expression Is an Adverse Prognostic Factor in Newly Diagnosed Multiple MyelomaNing, Xueqin; Wei, Yongqiang; Wei, Xiaolei; Feng, Ru; Chen, Bingyuan; Yi, Zhengshan; Zheng, Zhongxin63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.被引 1
- Systematic Construction of an Autophagic Risk Model in Bone Marrow for Prognostic Prediction in Multiple MyelomaShu, Lingling; Huang, Han-Ying; Liu, Yang; Li, Yang; Wang, Weida; Li, Jinyuan; Chen, Shuzhao; Wu, Xiaoping; Wang, Yun; Lin, Huanxin; Liang, Yang63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, 2021-12-11 To 2021-12-14.
- Identification and Validation of High-Risk Genes Contributing to Poor Prognosis in Multiple Myeloma Patients with chr1q Gain/AmplificationZhang, Shanshan; Cai, Linjing; Huan, Chen; Wang, Yuqi; Liu, Qifa; Wei, Xiaolei65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
期刊论文
Comprehensive analysis and establishment of a prognostic model based on non-genetic predictors in multiple myeloma (vol 38, pg 49, 2023)
11阅读
